Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

NCT06882551 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema (DME)

Interventions

DRUG: Intravitreal Bevacizumab IVB
DRUG: intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Sponsor

Khyber Teaching Hospital